Navigation Links
Protein may represent a switch to turn off B cell lymphoma
Date:5/7/2012

Researchers studying the molecular signals that drive a specific type of lymphoma have discovered a key biological pathway leading to this type of cancer. Cancerous cells have been described as being "addicted" to certain oncogenes (cancer-causing genes), and the new research may lay the groundwork for breaking that addiction and effectively treating aggressive types of B cell lymphoma.

B cell lymphomas, which occur both in children and adults, are cancers that attack B cells in the immune system.

"Our research suggests ways to devise more specific therapies to selectively kill tumor cells in a subset of lymphomas," said study leader Andrei Thomas-Tikhonenko, Ph.D., an oncology researcher at The Children's Hospital of Philadelphia.

The study, conducted in animal cells and human cell cultures, appeared May 1 in The Journal of Clinical Investigation.

An oncogene is a type of gene that normally produces a protein active in cell growth or regulation. However, when the gene is mutated or otherwise overproduced, it can cause cancer. One family of oncogenes is called MYC, and the current study focused on how the MYC oncogene drives B cell lymphoma. MYC codes for Myc, a type of protein called a transcription factor. At high levels, Myc causes the uncontrolled cell growth that is a hallmark of cancer.

The researchers focused on the crucial role of the cell surface receptor CD19, a protein residing on the surface of all B cells that normally recognizes foreign invaders. "We found that CD19 is absolutely required to stabilize the Myc protein," said Thomas-Tikhonenko. "When Myc is stable and present in high levels, it fuels cancer." Patients with high levels of the Myc protein are more likely to die of lymphoma.

Patients with high levels of Myc also had high levels of CD19, and the current study describes a previously unknown molecular pathway that depends on CD19. It also implicates CD19 as a molecular on-off switch on that pathway. Usually, said Thomas-Tikhonenko, when you inhibit one pathway, another pathway compensates to produce the same end result. But in this case, there is no such redundant pathway: "Without CD19, there is no Myc," he added, "so controlling that on-off switch could represent a powerful tool against lymphoma."

The findings are particularly relevant, said Thomas-Tikhonenko, to current oncology clinical trials that are testing antibodies that act broadly against the CD19 receptor. Such antibodies kill all B cells, and thus weaken the immune system. His study suggests that understanding the CD19 pathway could enable researchers to design a more specific therapy that selectively kills tumor cells while sparing healthy B cells.

Further studies in his lab, he added, will further investigate these molecular pathways and how to translate this knowledge into future anti-cancer treatments.


'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert

Related medicine news :

1. New and Delicious, Almond Butter Filled, Cookie Bites With 35.7% Protein to Help Manage Weight and Build Muscle
2. Research highlights role of protein pair in obesity regulation
3. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
4. Smithfield, United Food and Commercial Workers Union, and Food Networks Paula Deen to Deliver 150,000 Servings of Protein to San Francisco Food Bank
5. Protein Sciences Corporation Announces Profitable and Cash Flow Positive Results for 2009 and Management Realignment
6. Protein Appears Key to Intestinal Balance
7. SIBLING proteins may predict oral cancer
8. Damaged protein identified as early diagnostic biomarker for Alzheimers disease in healthy adults
9. Cells of aggressive leukemia hijack normal protein to grow
10. Omega Protein Comments on California Lawsuit Alleging Fish Oil Contaminants
11. Proteins May Predict Spread of Colon Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2018)... (PRWEB) , ... December 07, 2018 , ... Caring.com, the ... a leading provider of innovative medical alert systems, to its list of top medical ... for Premium Features . , Medical Guardian was one of fourteen companies that qualified ...
(Date:12/6/2018)... ... December 06, 2018 , ... Tea infusions made ... faster than the drug most commonly used against the ailment—and with no adverse ... The study’s authors, including a professor and two research associates at Worcester Polytechnic ...
(Date:12/6/2018)... ... December 06, 2018 , ... The University of Utah’s Gymnastics team ... fixtures containing Indigo-Clean continuous environmental disinfection. The lights are installed in the ... collegiate gymnastics programs across the nation by providing this new, proven bacteria fighting technology ...
(Date:12/5/2018)... ... 05, 2018 , ... Body by Ravi Plastic Surgery and ... Houston to offer the BodyTitePRO treatment. Dr. Ravi Somayazula , practice founder, ... and noninvasive techniques to improve the face, breast and body. Together with his ...
(Date:12/5/2018)... ... December 05, 2018 , ... Marking its seventh year, Pacifica ... “A Toast Heard ‘Round the World” on New Year’s Eve. Each year event ... community (alumni, students, faculty members, staff, families, and friends of the institution) to join ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... December 05, 2018 , ... WHO: The Institute for ... Livestreaming of four keynote addresses and five spotlight sessions taking place during ... for session descriptions and speakers) , WHEN: Beginning Tuesday, December 11 ( full schedule ...
(Date:12/5/2018)... ... 2018 , ... Florida Hospital West Florida Division has once ... prestigious Leapfrog Group, a national nonprofit health care ratings organization, announced the Top ... Sebring, Florida Hospital Wesley Chapel and Florida Hospital Zephyrhills all received the Top ...
(Date:12/5/2018)... FALLS, S.D. (PRWEB) , ... December 05, 2018 , ... ... the inaugural $1 million Sanford Lorraine Cross Award. , Jean Bennett, M.D., Ph.D., ... inherited form of blindness, accepted the award on Dec. 4 at Sanford Health, headquartered ...
Breaking Medicine Technology: